{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:52:29Z","timestamp":1785689549474,"version":"3.56.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cld.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T21:17:08Z","timestamp":1656105428000},"page":"473-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Wilson Disease in Children"],"prefix":"10.1016","volume":"26","author":[{"given":"Nanda","family":"Kerkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2022.03.008_bib1","doi-asserted-by":"crossref","unstructured":"Tanner S: A History of Wilson Disease. In: Kerkar N, Roberts EA, eds Clinical and Translational Perspectives on Wilson Disease, Elsevier Publications: Academic press; London (UK): 2019; 1-11.","DOI":"10.1016\/B978-0-12-810532-0.00001-X"},{"key":"10.1016\/j.cld.2022.03.008_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0113s39","article-title":"The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution","author":"Stenson","year":"2012","journal-title":"Curr Protoc Bioinformatics"},{"key":"10.1016\/j.cld.2022.03.008_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson's disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.03.008_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ng1293-327","article-title":"The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene","volume":"5","author":"Bull","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.03.008_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng1293-338","article-title":"Mapping, cloning and genetic characterization of the region containing the Wilson disease gene","volume":"5","author":"Petrukhin","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.03.008_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ng1293-344","article-title":"The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene","volume":"5","author":"Tanzi","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.03.008_bib7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.03.008_bib8","doi-asserted-by":"crossref","first-page":"846S","DOI":"10.1093\/ajcn\/63.5.846","article-title":"Limits of metabolic tolerance to copper and biological basis for present recommendations and regulations","volume":"63","author":"Olivares","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cld.2022.03.008_bib9","doi-asserted-by":"crossref","unstructured":"Sokol R, Silverman A: Copper metabolism and copper storage disorders in children. In: Suchy F, Sokol R, Balistreri W, Bezerra J, Mack C, Shneider B, eds Liver Disease in Children. 5th ed: Cambridge, 2021; 484-514.","DOI":"10.1017\/9781108918978.028"},{"key":"10.1016\/j.cld.2022.03.008_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bpj.2015.11.025","article-title":"How mammalian cells acquire copper: an essential but potentially toxic metal","volume":"110","author":"Kaplan","year":"2016","journal-title":"Biophys J"},{"key":"10.1016\/j.cld.2022.03.008_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Czlonkowska","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cld.2022.03.008_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.cld.2022.03.008_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1179\/1743132813Y.0000000262","article-title":"Comprehensive analysis on clinical features of Wilson's disease: an experience over 28 years with 133 cases","volume":"36","author":"Lin","year":"2014","journal-title":"Neurol Res"},{"key":"10.1016\/j.cld.2022.03.008_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00716470","article-title":"Presenting symptoms and natural history of Wilson disease","volume":"146","author":"Saito","year":"1987","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cld.2022.03.008_bib15","first-page":"253","article-title":"Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients","volume":"70","author":"Walshe","year":"1989","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.cld.2022.03.008_bib16","first-page":"281","article-title":"Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases","volume":"238","author":"Oder","year":"1991","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2007.02.057","article-title":"Late-onset Wilson's disease","volume":"132","author":"Ferenci","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.03.008_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-63625-6.00010-0","article-title":"Wilson disease: neurologic features","volume":"142","author":"Czlonkowska","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","article-title":"Neurologic Wilson's disease","volume":"1184","author":"Lorincz","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cld.2022.03.008_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","article-title":"EASL clinical practice guidelines: Wilson's disease","volume":"56","author":"European Association for Study of L","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/B978-0-444-63625-6.00014-8","article-title":"Diagnosis of wilson disease","volume":"142","author":"Ferenci","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0016-5085(91)90294-U","article-title":"Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure","volume":"100","author":"Berman","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.03.008_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.PCC.0000074268.77622.DE","article-title":"Fulminant Wilson's disease in children: appraisal of a critical diagnosis","volume":"4","author":"Tissieres","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.cld.2022.03.008_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1203\/00006450-197410000-00001","article-title":"Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood","volume":"8","author":"Matsuda","year":"1974","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cld.2022.03.008_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/185693a0","article-title":"Turnover of the copper and protein moieties of ceruloplasmin","volume":"185","author":"Gitlin","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.cld.2022.03.008_bib26","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1172\/JCI104407","article-title":"The incorporation of copper into ceruloplasmin in\u00a0Vivo: Studies with copper and copper","volume":"40","author":"Sternlieb","year":"1961","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.03.008_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1542-3565(05)00181-3","article-title":"Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease","volume":"3","author":"Ferenci","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/jhep.2003.50252","article-title":"Division of G, Nutrition HfSCTOC. A practice guideline on wilson disease","volume":"37","author":"Roberts","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.03.008_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2007-999143","article-title":"[Wilson's disease with primary CNS manifestation--current status in diagnosis and therapy]","volume":"60","author":"Willeit","year":"1992","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.cld.2022.03.008_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1478-3231.2005.01072.x","article-title":"Evaluation of the scoring system for the diagnosis of Wilson's disease in children","volume":"25","author":"Koppikar","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2022.03.008_bib31","doi-asserted-by":"crossref","unstructured":"Kyrana E, Sintusek P, Dhawan A: Role of Scoring Systems in Wilson Disease. In: Kerkar N, Roberts EA, editors. Clinical and Translational Perspectives on Wilson Disease, Elsevier Publications: Academic press; London(UK): 2019; 279-285.","DOI":"10.1016\/B978-0-12-810532-0.00025-2"},{"key":"10.1016\/j.cld.2022.03.008_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/gut.27.11.1377","article-title":"Wilson's disease: clinical presentation and use of prognostic index","volume":"27","author":"Nazer","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.03.008_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/lt.20352","article-title":"Wilson's disease in children: 37-year experience and revised King's score for liver transplantation","volume":"11","author":"Dhawan","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2022.03.008_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(60)90109-4","article-title":"Treatment of Wilson's disease with penicillamine","volume":"1","author":"Walshe","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.03.008_bib35","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","article-title":"Efficacy and safety of oral chelators in treatment of patients with Wilson disease","volume":"11","author":"Weiss","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(56)90066-3","article-title":"Penicillamine, a new oral therapy for Wilson's disease","volume":"21","author":"Walshe","year":"1956","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2022.03.008_bib37","first-page":"153","article-title":"[D-penicillamine-induced pemphigus, polymyositis and myasthenia]","volume":"126","author":"Jan","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.cld.2022.03.008_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/1531-8257(199907)14:4<551::AID-MDS1002>3.0.CO;2-S","article-title":"Penicillamine should not be used as initial therapy in Wilson's disease","volume":"14","author":"Brewer","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.cld.2022.03.008_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000355276","article-title":"Worsening of Wilson disease following penicillamine therapy","volume":"71","author":"Kalita","year":"2014","journal-title":"Eur Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2015.06.010","article-title":"Early neurological worsening in patients with Wilson's disease","volume":"355","author":"Litwin","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.cld.2022.03.008_bib41","first-page":"264","article-title":"Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease","volume":"30","author":"Dziezyc","year":"2015","journal-title":"Funct Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1440-1746.1990.tb01420.x","article-title":"Liver copper concentration in Wilson's disease: effect of treatment with 'anti-copper' agents","volume":"5","author":"Gibbs","year":"1990","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdd.2510130406","article-title":"Comparison of disposition behavior and de-coppering effect of triethylenetetramine in animal model for Wilson's disease (Long-Evans Cinnamon rat) with normal Wistar rat","volume":"13","author":"Iseki","year":"1992","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.cld.2022.03.008_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0404.1991.tb03964.x","article-title":"Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease","volume":"83","author":"Siegemund","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.cld.2022.03.008_bib45","first-page":"77","article-title":"Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine)","volume":"10","author":"Dubois","year":"1990","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2022.03.008_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MPG.0000000000002902","article-title":"Optimized trientine-dihydrochloride therapy in pediatric patients with wilson disease: is weight-based dosing justified?","volume":"72","author":"Mayr","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2022.03.008_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-2143(03)00157-4","article-title":"Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc","volume":"142","author":"Askari","year":"2003","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.cld.2022.03.008_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jocn.2012.02.041","article-title":"Trientine-induced neurological deterioration in a patient with Wilson's disease","volume":"20","author":"Kim","year":"2013","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.cld.2022.03.008_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.reprotox.2016.06.015","article-title":"Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database","volume":"65","author":"Dathe","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.cld.2022.03.008_bib50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-99-3-314","article-title":"Oral zinc therapy for Wilson's disease","volume":"99","author":"Brewer","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2022.03.008_bib51","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1172\/JCI78991","article-title":"Elevated copper impairs hepatic nuclear receptor function in Wilson's disease","volume":"125","author":"Wooton-Kee","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.03.008_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MPG.0000000000001787","article-title":"Wilson's disease in children: a position paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"Socha","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2022.03.008_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mlc.2001.113037","article-title":"Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years","volume":"137","author":"Brewer","year":"2001","journal-title":"J\u00a0Lab Clin Med"},{"issue":"Suppl","key":"10.1016\/j.cld.2022.03.008_bib54","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jhep.2004.11.013","article-title":"Wilson's disease: clinical management and therapy","volume":"42","author":"Brewer","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib55","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1111\/j.1399-0012.2010.01327.x","article-title":"Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults","volume":"25","author":"Arnon","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2022.03.008_bib56","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/lt.20486","article-title":"Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders","volume":"11","author":"Medici","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2022.03.008_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cld.2022.03.008_bib58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2468-1253(17)30293-5","article-title":"Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study","volume":"2","author":"Weiss","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib59","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1172\/JCI85226","article-title":"Methanobactin reverses acute liver failure in a rat model of Wilson disease","volume":"126","author":"Lichtmannegger","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.03.008_bib60","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.23209","article-title":"Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin","volume":"50","author":"van den Berghe","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.03.008_bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/lt.22466","article-title":"Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease","volume":"18","author":"Sauer","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2022.03.008_bib62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2015.09.014","article-title":"Long-term metabolic correction of Wilson's disease in a murine model by gene therapy","volume":"64","author":"Murillo","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.03.008_bib63","unstructured":"ClinicalTrials.gov. A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Seamless, Adaptive, Safety, Dose-Finding, and Phase 3 Clinical Study of UX701 AAV-Mediated Gene Transfer for the Treatment of Wilson Disease. In; 2021."}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:33Z","timestamp":1761069573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1089326122000228"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.03.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wilson Disease in Children","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}